Who Benefits Most From Early Rhythm Control in Newly Diagnosed Atrial Fibrillation?

Affiliations

¹ Division of Cardiology, Inova Heart and Vascular Institute, Falls Church, VA (E.Y.).
² Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (E.Y., H.C.).

Editorial

Eunice Yang et al. Circulation. 2022.

. 2022 Sep 13;146(11):848-850.

doi: 10.1161/CIRCULATIONAHA.122.060945. Epub 2022 Sep 12.

¹ Division of Cardiology, Inova Heart and Vascular Institute, Falls Church, VA (E.Y.).
² Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (E.Y., H.C.).

No abstract available

Keywords: Editorials; ablation techniques; anti-arrhythmia agents; atrial fibrillation; comorbidity; controlled clinical trial; stroke.

Comment on

Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
Rillig A, Borof K, Breithardt G, Camm AJ, Crijns HJGM, Goette A, Kuck KH, Metzner A, Vardas P, Vettorazzi E, Wegscheider K, Zapf A, Kirchhof P. Rillig A, et al. Circulation. 2022 Sep 13;146(11):836-847. doi: 10.1161/CIRCULATIONAHA.122.060274. Epub 2022 Aug 15. Circulation. 2022. PMID: 35968706 Clinical Trial.